
Sanofi disclosed the total number of its issued shares and voting rights as of April 30, 2026. The company has issued 1,212,212,936 shares, with 1,329,027,146 real voting rights excluding treasury shares, and a theoretical total of 1,346,241,660 voting rights including treasury shares. This update complies with French commercial regulations and is relevant for shareholders and investors tracking ownership and control stakes. The information is publicly available on Sanofi's investor relations website for transparency and regulatory compliance.